Open AccessCombined application of bevacizumab and PD-1 blockade displays durable treatment effects by increasing the infiltration and cytotoxic function of CD8+T cells in lung cancer
Author(s) -
Yanxia Liu,
Tongmei Zhang,
Lina Zhang,
Cong Zhao,
Zhiyun Zhang,
Ziyu Wang,
Meng Gu,
Weiying Li,
Baolan Li
Publication year - 2022
Publication title -
immunotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.127
H-Index - 48
eISSN - 1750-7448
pISSN - 1750-743X
DOI - 10.2217/imt-2021-0196
Subject(s) - bevacizumab , cytotoxic t cell , lung cancer , medicine , cd8 , antibody , immune system , cancer research , population , immunotherapy , blockade , pharmacology , immunology , chemotherapy , chemistry , receptor , in vitro , biochemistry , environmental health